Morningside Venture Investments Ltd Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Morningside Venture Investments LTD is > 10% Shareholder of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 12.8 Million shares of APLS, which is worth approximately $479 Million. The most recent transaction as insider was on Nov 18, 2021, when has been sold 250,000 shares (Common Stock) at a price of $40.0 per share, resulting in proceeds of $10,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8M

0% 3M change

0% 12M change

Total Value Held $479 Million

Morningside Venture Investments Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 18 2021	BUY Open market or private purchase	$10,000,000 $40.0 p/Share	250,000 Added 1.91%	12,806,342 Common Stock

Also insider at

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

GRNA

GreenLight Biosciences Holdings, PBC Healthcare

KZR

Kezar Life Sciences, Inc. Healthcare

MVI